News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Skolnick Phil
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/03/2023 |
4
| Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 9,812 shares
@ $20, valued at
$196.2k
Disposed/sold 11,736 shares
@ $20, valued at
$234.7k
Granted 2,000 shares
@ $0
Disposed/sold 2,000 shares
@ $20, valued at
$40k
Disposed/sold 40,000 options to buy
@ $9, valued at
$360k
Disposed/sold 13,200 options to buy
@ $13.61, valued at
$179.7k
Disposed/sold 8,250 options to buy
@ $13.6, valued at
$112.2k
Disposed/sold 10,750 options to buy
@ $12.15, valued at
$130.6k
|
|
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 369 shares
@ $20.2, valued at
$7.5k
|
|
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2022 |
4
| Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 1,518 shares
@ $26.19, valued at
$39.8k
|
|
| 01/12/2022 |
4
| Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 385 shares
@ $30.49, valued at
$11.7k
|
|
| 01/05/2022 |
4
| Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Granted 12,000 shares
@ $0 |
|
| 01/27/2021 |
4
| Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Granted 2,798 shares
@ $0
Granted 5,400 shares
@ $0
Granted 10,750 options to buy
@ $12.15, valued at
$130.6k
|
|
| 01/09/2020 |
4
| Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 2,900 shares
@ $13.6, valued at
$39.4k
Granted 4,150 shares
@ $0
Sold 2,842 shares
@ $13.46, valued at
$38.3k
Sold 3,043 shares
@ $13.36, valued at
$40.7k
Granted 8,250 options to buy
@ $13.6, valued at
$112.2k
|
|
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2019 |
4
| Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 2,057 shares
@ $13.74, valued at
$28.3k
Sold 800 shares
@ $13.34, valued at
$10.7k
|
|
| 12/04/2019 |
4
| Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 2,565 shares
@ $14.17, valued at
$36.3k
Sold 4,578 shares
@ $13.93, valued at
$63.8k
Exercised 10,000 options to buy
@ $9, valued at
$90k
|
|
| 11/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/04/2019 |
4
| Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 7,506 shares
@ $14.08, valued at
$105.7k
Sold 2,494 shares
@ $14.37, valued at
$35.8k
Exercised 10,000 options to buy
@ $9, valued at
$90k
|
|
| 08/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2019 |
4
| Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 8,414 shares
@ $11.72, valued at
$98.6k
Sold 1,586 shares
@ $11.63, valued at
$18.4k
Exercised 10,000 options to buy
@ $9, valued at
$90k
|
|
| 05/03/2019 |
4
| Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 8,559 shares
@ $11.41, valued at
$97.7k
Sold 1,441 shares
@ $11.24, valued at
$16.2k
Exercised 10,000 options to buy
@ $9, valued at
$90k
|
|
| 04/03/2019 |
4
| Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 7,993 shares
@ $12.71, valued at
$101.6k
Sold 2,007 shares
@ $12.47, valued at
$25k
Exercised 10,000 options to buy
@ $9, valued at
$90k
|
|
| 03/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2019 |
4
| Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 7,768 shares
@ $13.84, valued at
$107.5k
Sold 2,232 shares
@ $13.48, valued at
$30.1k
Exercised 10,000 options to buy
@ $9, valued at
$90k
Granted 13,200 options to buy
@ $13.61, valued at
$179.7k
|
|
| 12/06/2018 |
4
| Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 1,306 shares
@ $15.85, valued at
$20.7k
Sold 3,015 shares
@ $16.15, valued at
$48.7k
Exercised 10,000 options to buy
@ $9, valued at
$90k
|
|
| 11/08/2018 |
4
| Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 3,217 shares
@ $16.81, valued at
$54.1k
|
|
| 11/05/2018 |
4
| Skolnick Phil (Chief Scientific Officer) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Sold 1,521 shares
@ $18.14, valued at
$27.6k
Sold 300 shares
@ $17.33, valued at
$5.2k
Exercised 10,000 options to buy
@ $9, valued at
$90k
|
|
| 10/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/13/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|